
化学名称 : AC220/AC-220
CAS : 950769-58-1
英文名称: AC220/AC-220
英文同义词: N-(5-TERT-BUTYLISOXAZOL-3-YL)-N'-[4-[7-(2-MORPHOLIN-4-YLETHOXY)IMIDAZO[2,1-B][1,3]BENZOTHIAZOL-2-YL]PHENYL]UREA
同义词: N-(5-TERT-BUTYLISOXAZOL-3-YL)-N'-[4-[7-(2-MORPHOLIN-4-YLETHOXY)IMIDAZO[2,1-B][1,3]BENZOTHIAZOL-2-YL]PHENYL]UREA
Storage:at -20℃ 2 years
Biologieal
AC220 is a uniquely potent and selective FLT3 inhibitor with IC50 of 0.56 ± 0.3 nM and >10 mM for MC4-11 and A375, respectively. It exhibits low nanomolar potency in biochemical and cellular assays and exceptional kinase selectivity, and in animal models is efficacious at doses as low as 1 mg/kg given orally once daily. The data reveal that the combination of excellent potency, selectivity, and pharmacokinetic properties is unique to AC220, which therefore is the first drug candidate with a profile that matches the characteristics desirable for a clinical FLT3 inhibitor.
Reference
[1] Zarrinkar PP et a. Blood. 2009 Oct 1;114(14):2984-92
CX-4945/CX4945
1009820-21-6
UK-5099/UK5099/
56396-35-1
PF-04217903/PF04217903
1159490-85-3
4-(2-Chlorophenoxy)-N-[3-[(methylamino)carbonyl]phenyl]-1-piperidinecarboxamide
1032229-33-6